Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

beta-Lactamase induction and cell wall recycling in gram-negative bacteria.

Wiedemann B, Pfeifle D, Wiegand I, Janas E.

Drug Resist Updat. 1998;1(4):223-6.

PMID:
16904404
2.

A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.

Burch PA, Bernath AM, Cascino TL, Scheithauer BW, Novotny P, Nair S, Buckner JC, Pfeifle DM, Kugler JW, Tschetter LK.

Invest New Drugs. 2000 Aug;18(3):275-80.

PMID:
10958598
3.

Role of penicillin-binding proteins in the initiation of the AmpC beta-lactamase expression in Enterobacter cloacae.

Pfeifle D, Janas E, Wiedemann B.

Antimicrob Agents Chemother. 2000 Jan;44(1):169-72.

4.

A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma.

Creagan ET, Veeder MH, Suman VJ, Burch PA, Maples WJ, Schaefer PL, Pfeifle DM, Dalton RJ, Hatfield AK, Poon MA.

Am J Clin Oncol. 1998 Oct;21(5):475-8.

PMID:
9781603
5.

Induction of beta-lactamase in Enterobacter cloacae.

Wiedemann B, Dietz H, Pfeifle D.

Clin Infect Dis. 1998 Aug;27 Suppl 1:S42-7.

PMID:
9710670
6.

The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide.

Dietz H, Pfeifle D, Wiedemann B.

Antimicrob Agents Chemother. 1997 Oct;41(10):2113-20.

7.

Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

Elliott TE, Dinapoli RP, O'Fallon JR, Krook JE, Earle JD, Morton RF, Levitt R, Tschetter LK, Scheithauer BW, Pfeifle DM, Twito DI, Nelimark RA.

J Neurooncol. 1997 Jul;33(3):239-50.

PMID:
9195495
9.

Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinoma.

Long HJ 3rd, Langdon RM Jr, Cha SS, Veeder MH, Pfeifle DM, Krook JE, Ebbert LP, Tschetter LK, Roshon SG.

Gynecol Oncol. 1995 Aug;58(2):240-3.

PMID:
7622111
10.

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.

Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, et al.

J Clin Oncol. 1994 Jun;12(6):1126-9.

PMID:
8201374
11.

A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.

Ingle JN, Mailliard JA, Schaid DJ, Krook JE, Gesme DH Jr, Windschitl HE, Pfeifle DM, Etzell PS, Gerstner JG, Long HJ, et al.

Cancer. 1991 Jul 1;68(1):34-9.

PMID:
2049750
12.

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer.

Krook JE, O'Connell MJ, Wieand HS, Beart RW Jr, Leigh JE, Kugler JW, Foley JF, Pfeifle DM, Twito DI.

Cancer. 1991 May 15;67(10):2454-8.

PMID:
2015545
13.

A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.

Windschitl HE, O'Connell MJ, Wieand HS, Krook JE, Rubin J, Moertel CG, Kugler JW, Pfeifle DM, Goldberg RM, Laurie JA.

Cancer. 1990 Sep 1;66(5):853-6.

PMID:
2201430
14.

Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer. A collaborative North Central Cancer Treatment Group/Mayo Clinic phase II study.

Krook JE, Loprinzi CL, Schaid DJ, Kardinal CG, Mailliard JA, Pfeifle DM, Ellison NM, Reuter NF, Nelimark RA.

Cancer. 1990 Feb 1;65(3):418-21.

PMID:
2297632
15.

Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.

Ingle JN, Mailliard JA, Schaid DJ, Krook JE, Gerstner JB, Pfeifle DM, Marschke RF Jr, Long HJ, McCormack GW, Foley JF.

Am J Clin Oncol. 1989 Dec;12(6):474-80.

PMID:
2686393
16.

Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.

Marschke RF Jr, Ingle JN, Schaid DJ, Krook JE, Mailliard JA, Cullinan SA, Pfeifle DM, Votava HJ, Ebbert LP, Windschitl HE.

Cancer. 1989 May 15;63(10):1931-7.

PMID:
2649221
17.

Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer.

Buckner JC, Ingle JN, Everson LK, O'Fallon JR, Cullinan SA, Ahmann DL, Krook JE, Pfeifle DM.

Breast Cancer Res Treat. 1989 Mar;13(2):135-42.

PMID:
2659104
18.

Phase II evaluation of carboplatin in advanced endometrial carcinoma.

Long HJ, Pfeifle DM, Wieand HS, Krook JE, Edmonson JH, Buckner JC.

J Natl Cancer Inst. 1988 Apr 20;80(4):276-8.

PMID:
3280811
19.

Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure.

Ingle JN, Pfeifle DM, Green SJ, Kvols LK, Brunk SF, Reuter NF, Krook JE, Laurie JA, Everson LK, Marschke RF, et al.

Am J Clin Oncol. 1985 Aug;8(4):275-82.

PMID:
3909798
20.

Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.

Krook JE, Ingle JN, Green SJ, Bowman WD, Everson LK, Windschitl HE, Marschke RF, Laurie JA, Cullinan SA, Pfeifle DM, et al.

Cancer Treat Rep. 1985 Apr;69(4):355-61.

PMID:
3888386
21.

Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.

Krook JE, Fleming TR, Eagan RT, Cullinan S, Pfeifle D, Elliott T, Etzell P.

Cancer Treat Rep. 1984 Mar;68(3):493-8.

PMID:
6322987

Supplemental Content

Loading ...
Support Center